A major new all-island study is set to change how prostate cancer is treated, with a focus not just on survival, but on quality of life.
The INSPIRE trial aims to reduce the side-effects of radiotherapy while maintaining strong cancer control, using more precise, shorter treatment methods.
- Advertisement -
To discuss this, Alan Morrissey spoke with Angela Clayton-Lea, CEO of Cancer Trials Ireland and Martin Sweeney a man who was diagnosed with prostate cancer and who was involved in the design of the trial on Thursday’s edition of Morning Focus.
You can listen to the full interview below:
